Advertisement

Microspheres as a Potential Controlled Release Nasal Drug Delivery System

  • Lisbeth Illum
Part of the NATO ASI Series book series (NSSA, volume 125)

Abstract

The epithelial cells of the nasal mucosa are for the main part of the nasal cavity covered with numerous microvilli thereby increasing considerably the surface available for drug absorption. Furthermore, the subepithelial layer is highly vascularized with large and fenestrated capillaries specially designed for rapid passage of fluid through the vascular wall (Mygind, 1978). Unlike absorption from the gastrointestinal tract the venous blood draining from the nose passes directly into the systemic circulation and not into the portal circulation and thence to the liver. Thus, the nose is well suited for the absorption of drugs, especially those that are extensively metabolized in the gastrointestinal fluids and the gut wall or are subjected to an extensive first pass hepatic metabolism. The various regulatory peptides and proteins are good examples.

Keywords

Nasal Cavity Nasal Mucosa Nasal Spray Polyacrylic Acid Penetration Enhancer 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Aoki, F.Y. and Crawley, J.C.W., 1976, Distribution and removal of human serum albumin — technetium 99m instilled intranasally, Br. J. Clin. Pharmac., 3: 869.CrossRefGoogle Scholar
  2. Berquist, C., Nillins, S.J. and Wide, L., 1979, Intranasal gonadotropin-releasing hormone agonist as a contraceptive agent, Lancet, 2: 215.CrossRefGoogle Scholar
  3. David, G.F.X., Puri, C.P. and Anaud Kumar, T.C:, 1981, Bioavailability of progesterone enhanced by intranasal spraying, Experientia, 37: 533.PubMedCrossRefGoogle Scholar
  4. Dudley, R.E., Muggenburg, B.A., Cuddihy, R.G. and McClellan, R.O., 1980, Nasal absorption of DTPA in rats, Health Phys., 38: 763.PubMedCrossRefGoogle Scholar
  5. Evans, W.S., Borges, J.L.C., Kaiser, D.L., Vance, M.L., Seller, R.P., Macleod, R.M., Vale, W., Rivier, J. and Thorner, M.O. 1983, Intranasal administration of human pancreatic tumor GH-releasing factor-40 stimulates GH release in normal men. J. Clin. Endocrinol. Metab., 57: 1081.PubMedCrossRefGoogle Scholar
  6. Hardy, J.G., Lee, S.W. and Wilson, C.G., 1985, Intranasal drug delivery by sprays and drops, J. Pharm. Pharmacol., 37: 294.PubMedCrossRefGoogle Scholar
  7. Hirai, S., Yashiki, T. and Mima, H., 1981, Mechanisms for the enhancement of the nasal absorption of insulin by surfactants, Int. J. Pharm., 9: 173.CrossRefGoogle Scholar
  8. Hussain, A., Foster, T., Hirai, S., Kashihara, T., Batenhorst, R. and Jones, M., 1980a, Nasal absorption of propranolol in humans, J. Pharm. Sci., 69: 1240.PubMedCrossRefGoogle Scholar
  9. Hussain, A., Hirai, S. and Bawarski, R., 1979, Nasal absorption of propranolol in rats, J. Pharm. Sci., 68: 1196.PubMedCrossRefGoogle Scholar
  10. Hussain, A., Hirai, S. and Bawarski, R., 1980b, Nasal absorption of propranolol from different dosage forms by rats and dogs, J. Pharm. Sci., 69: 1411.PubMedCrossRefGoogle Scholar
  11. Ilium, L., Jorgensen, H., Bisgaard, H., Krogsgaard, O. and Rossing, N., Bioadhesive microspheres as a potential nasal drug delivery system (to be published).Google Scholar
  12. Morimoto, K., Morisaka, K. and Kamada, A., 1985, Enhancement of nasal absorption of insulin and calcitonin using polyacrylic acid gel, J. Pharm. Pharmacol., 37: 134.PubMedCrossRefGoogle Scholar
  13. Moses, A.C., Gordon, G.S., Carey, M.C. and Flier, J.S., 1983, Insulin administered intranasally as an insulin-bile salt aerosol: effectiveness and reproducibility in normal and diabetic subjects. Diabetes, 32: 1040.PubMedCrossRefGoogle Scholar
  14. Mygind, N., 1978, “Nasal Allergy”, Blackwell Scientific Publications, Oxford.Google Scholar
  15. Nagai, T., Nishimoto, Y., Nambu, N., Suzuki, Y. and Sekine, K., 1984, Powder dosage form of insulin for nasal administration, J. Control. Rel., 1: 15.CrossRefGoogle Scholar
  16. Salzman, R., Manson, J.E., Griffing, G.T., Kimmerle, R., Ruderman, N., McCall, A., Stoltz, E.I., Mullin, C., Small, D., Armstrong, J. and Melby, J.C:, 1985, Intranasal aerosolized insulin, N. Eng. J. Med., 312: 1078.CrossRefGoogle Scholar
  17. Su, K.S.E., Campanale, K.M., Mendelsohn, L.G., Kerchner, G.A. and Gries, CL., 1985, Nasal delivery of polypeptides, I: nasal absorption of enkephalins, J. Pharm. Sci., 74: 394.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 1986

Authors and Affiliations

  • Lisbeth Illum
    • 1
  1. 1.Depart. of PharmaceuticsRoyal Danish School of PharmacyCopenhagenDenmark

Personalised recommendations